JP2024528097A5 - - Google Patents

Info

Publication number
JP2024528097A5
JP2024528097A5 JP2024505421A JP2024505421A JP2024528097A5 JP 2024528097 A5 JP2024528097 A5 JP 2024528097A5 JP 2024505421 A JP2024505421 A JP 2024505421A JP 2024505421 A JP2024505421 A JP 2024505421A JP 2024528097 A5 JP2024528097 A5 JP 2024528097A5
Authority
JP
Japan
Prior art keywords
composition according
composition
xylitol
glycerol
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024505421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528097A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/071842 external-priority patent/WO2023012224A1/en
Publication of JP2024528097A publication Critical patent/JP2024528097A/ja
Publication of JP2024528097A5 publication Critical patent/JP2024528097A5/ja
Pending legal-status Critical Current

Links

JP2024505421A 2021-08-03 2022-08-03 上気道における微生物感染の治療のためのペプチダーゼ製剤 Pending JP2024528097A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21189429 2021-08-03
EP21189429.0 2021-08-03
PCT/EP2022/071842 WO2023012224A1 (en) 2021-08-03 2022-08-03 Peptidase formulation for treatment of microbial infections in the upper respiratory tract

Publications (2)

Publication Number Publication Date
JP2024528097A JP2024528097A (ja) 2024-07-26
JP2024528097A5 true JP2024528097A5 (cg-RX-API-DMAC7.html) 2025-08-07

Family

ID=77207007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024505421A Pending JP2024528097A (ja) 2021-08-03 2022-08-03 上気道における微生物感染の治療のためのペプチダーゼ製剤

Country Status (5)

Country Link
US (1) US20240173387A1 (cg-RX-API-DMAC7.html)
EP (1) EP4380549B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024528097A (cg-RX-API-DMAC7.html)
CN (1) CN117794513A (cg-RX-API-DMAC7.html)
WO (1) WO2023012224A1 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599883B1 (en) * 1998-10-30 2003-07-29 Nastech Pharmaceutical Company, Inc. Nasal delivery of xylitol
CN100584376C (zh) * 2006-05-25 2010-01-27 广西亚热带作物研究所 治疗深度带痂糜烂性创伤的药物
EP3121272A1 (en) * 2015-07-24 2017-01-25 Zymetech ehf. Novel fish trypsin isoforms and their use
GB201800274D0 (en) * 2018-01-08 2018-02-21 Enzymatica Ab Novel treatments
US11013687B1 (en) * 2020-06-08 2021-05-25 Amcyte Pharma, Inc. Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2

Similar Documents

Publication Publication Date Title
JP2004505046A5 (cg-RX-API-DMAC7.html)
RU2011137961A (ru) Фармацевтические составы и способы лечения инфекций дыхательных путей
JP2006516648A5 (cg-RX-API-DMAC7.html)
CN1270689C (zh) 固体口腔用抗牙垢和抗牙菌斑组合物
JP2004525928A5 (cg-RX-API-DMAC7.html)
JP2018523635A5 (cg-RX-API-DMAC7.html)
JP2007145876A5 (cg-RX-API-DMAC7.html)
JP2001199882A (ja) 感冒・鼻炎用組成物
JP2022537178A5 (cg-RX-API-DMAC7.html)
JP2022504181A5 (cg-RX-API-DMAC7.html)
JP2024528097A5 (cg-RX-API-DMAC7.html)
EP1841439B1 (en) Compositions comprising extracts from sanguinaria or macleaya, vaccinium myrtillus or vitis vinifera and echinacea angustifolia
JP2002332229A (ja) 感冒用組成物
JP6975473B2 (ja) 鼻詰まりを治療／予防するためのカルボン酸
JP2023532170A5 (cg-RX-API-DMAC7.html)
Treanor Respiratory infections
JP2000080036A (ja) 新規な治療方法
JP2002348240A (ja) 医薬組成物
JP2023518376A5 (cg-RX-API-DMAC7.html)
JP2023524064A5 (cg-RX-API-DMAC7.html)
JPH09175968A (ja) 口腔用組成物
TW200404550A (en) Cepharospolin formulation for oral use
JPS6326082B2 (cg-RX-API-DMAC7.html)
JPH0513129B2 (cg-RX-API-DMAC7.html)
EP2320870B1 (en) Topical intranasal composition usable in the case of nasal obstruction